<DOC>
	<DOCNO>NCT00040820</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Clinical trial study effectiveness oxaliplatin treat patient locally advance metastatic colorectal cancer previously treat .</brief_summary>
	<brief_title>Oxaliplatin Treating Patients With Previously Treated Locally Advanced Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Provide oxaliplatin patient previously treat locally advanced metastatic colorectal cancer exhaust approved therapy colorectal cancer . OUTLINE : This multicenter , Treatment Access Program study . Patients receive oxaliplatin IV 2 hour day 1 . Treatment repeat every 21 day 8 course absence disease progression unacceptable toxicity . Patients follow least 30 day . PROJECTED ACCRUAL : Approximately one patient per site per month accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm adenocarcinoma colon rectum amenable surgical resection potentially curative therapy Locally advance OR Metastatic disease Patients progress nonoxaliplatincontaining ( control ) arm SanofiSynthelabo secondline regulatory trial OR Patients exhaust approved therapy colorectal cancer ( include fluorouracil irinotecan ) receive least 2 prior independent/different chemotherapy regimen Documented radiological disease progression last anticancer treatment PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 75,000/mm3 Hepatic : SGOT SGPT great 6 time upper limit normal ( ULN ) Bilirubin great 2 mg/dL Alkaline phosphatase great 5 time ULN Renal : Creatinine great 1.5 time ULN Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study Adequate organ function medically stable No known concurrent peripheral neuropathy Absence deep tendon reflex sole neurologic abnormality allow PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 30 day since prior chemotherapy No prior oxaliplatinbased chemotherapy No concurrent investigational chemotherapy agent Endocrine therapy : Not specify Radiotherapy : At least 30 day since prior radiotherapy Surgery : See Disease Characteristics At least 30 day since prior major surgical procedure intervention Other : At least 30 day since prior anticancer therapy No concurrent anticancer agents No concurrent participation investigational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>